Overview
Prime contract obligationsObligation: money the government has legally committed to a contract. It is not the same as money paid. Example: $6M obligated of a $10M ceiling. Glossary, FY2021–FY2025
5 offices
Five complete fiscal years; FY2026 reported so far is in the trend
Five complete fiscal years; FY2026 reported so far is in the trend
Click a tile to open its page.
Click a state to open its page.
- South Carolina$3.78B · 15%
- California$2.98B · 12%
- Massachusetts$2.64B · 11%
- Maryland$1.75B · 7.0%
- District of Columbia$1.62B · 6.4%
- Texas$1.09B · 4.4%
- North Carolina$1.06B · 4.2%
- New Jersey$1.01B · 4.0%
- Illinois$978M · 3.9%
- New York$949M · 3.8%
- Pennsylvania$832M · 3.3%
- Georgia$780M · 3.1%
- Ohio$642M · 2.6%
- Virginia$618M · 2.5%
- Oregon$445M · 1.8%
- Minnesota$372M · 1.5%
- Florida$350M · 1.4%
- Rhode Island$225M · 0.9%
- Louisiana$150M · 0.6%
- Nevada$128M · 0.5%
- Indiana$98.4M · 0.4%
- Missouri$93.8M · 0.4%
- Colorado$70.7M · 0.3%
- Utah$51.4M · 0.2%
- Oklahoma$49.4M · 0.2%
- Washington$49.4M · 0.2%
- Connecticut$46.3M · 0.2%
- Michigan$41.4M · 0.2%
- Kentucky$26.2M · 0.1%
- New Hampshire$22.4M · 0.1%
- Arkansas$21M · 0.1%
- Arizona$20.7M · 0.1%
- Tennessee$19.5M · 0.1%
- Alabama$19.1M · 0.1%
- New Mexico$14.1M · 0.1%
- Alaska$5.36M · 0.0%
- Hawaii$2.51M · 0.0%
- Puerto Rico$2.07M · 0.0%
- Guam$510K · 0.0%
- Wyoming$264K · 0.0%
- South Dakota$175K · 0.0%
36 smaller, $10.3B together.
No US state recorded: $2.08B · 8.3%
The latest fiscal year is reported so far (hatched)
Hover over a year to see its value.
Insight $1.28B in FY2025, 73% below FY2021
Each cell is one week of a month: days 1–7, 8–14, 15–21, 22–28 or 29–31
Hover over a week to see its total.
Insight September held 62.0% of FY2025 obligations
Offices
Click a tile to open its page.
Offices by prime obligations, FY2021–FY2025
Each contracting office of the sub-agency; open one to see what it buys.
Showing 1–5 of 5 offices
| FY2021–FY2025, US$ | ||||||
|---|---|---|---|---|---|---|
| Small business | Last 10 FY | |||||
| BARDA - ASPR / DAAPPO / BARDA DCMA | 75A501 | $17,461,050,566 | 1,393 | 593 | 17% | |
| ASPR/ORM-SNS | 75A503 | $4,495,867,151 | 251 | 229 | 26% | |
| ASPR/DAAPPO/ORM HQ | 75A502 | $2,541,361,523 | 419 | 418 | 45% | |
| INDUSTRIAL BASED MANUFACTURING AND SUPPLY CHAIN (IBMSC) | 75A504 | $498,662,774 | 22 | 22 | 1.2% | |
| ASPR-ORM-HCORE | 75A505 | $134,696,463 | 28 | 28 | 21% | |
Contractors
Click a bar to open its page.
Everyone else: $14.4B (57.4%)
Insight The ten largest received 43%
Contractors by prime obligations, FY2021–FY2025
The largest registrations; a company with several registrations appears once per registration.
762 contractors were paid; the 25 largest are listed
Showing 1–10 of 25 contractors
| FY2021–FY2025, US$ | ||||
|---|---|---|---|---|
| Share | Last 10 FY | |||
| Advanced Technology International | 17 | $4,034,325,157 | 16% | |
| Emergent Product Development Gaithersburg Inc. | 6 | $1,257,673,771 | 5.0% | |
| Bavarian Nordic A/s | 1 | $880,609,421 | 3.5% | |
| Walgreen Co. | 2 | $824,772,454 | 3.3% | |
| Modernatx, Inc. | 2 | $755,097,717 | 3.0% | |
| Seqirus Inc. | 34 | $727,496,211 | 2.9% | |
| Amgen USA Inc. | 4 | $714,867,023 | 2.8% | |
| Agiliti Health Inc. | 8 | $537,633,018 | 2.1% | |
| Emergent Biosolutions Canada Inc. | 2 | $496,682,507 | 2.0% | |
| Mckesson Medical-surgical Government Solutions LLC | 57 | $471,369,839 | 1.9% | |
Industries
Click a tile to open its page.
Insight The top five codes took 74%
Industries by prime obligations, FY2021–FY2025
Each six-digit industry code; open one to see who wins it.
Showing 1–10 of 141 industries
| FY2021–FY2025, US$ | ||||
|---|---|---|---|---|
| Industry | Share | |||
| 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | $9,894,048,018 | 287 | 38% |
| 325412 | Pharmaceutical Preparation Manufacturing | $3,721,225,856 | 207 | 14% |
| 325414 | Biological Product (except Diagnostic) Manufacturing | $2,386,200,325 | 162 | 9.3% |
| 541715 | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | $1,684,545,611 | 111 | 6.5% |
| 621511 | Medical Laboratories | $1,480,329,188 | 8 | 5.8% |
| 325413 | In-Vitro Diagnostic Substance Manufacturing | $1,187,383,170 | 39 | 4.6% |
| 541711 | Research and Development in Biotechnology | $971,166,243 | 110 | 3.8% |
| 339112 | Surgical and Medical Instrument Manufacturing | $680,561,679 | 25 | 2.6% |
| 541990 | All Other Professional, Scientific, and Technical Services | $603,354,619 | 131 | 2.3% |
| 339113 | Surgical Appliance and Supplies Manufacturing | $485,542,584 | 91 | 1.9% |
Opportunities
Open opportunities from Office of Assistant Secretary for Preparedness and Response
1 of the next 4 are due within 30 days
Showing 1–4 of 4 opportunities
| Opportunity | Office | Due |
|---|---|---|
| BARDA Device Development for Scientists Training (opens in Procura)Solicitation · Set aside: Small business · NAICS 611430Free account: full notice, dates, attachments | ASPR ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE | Oct 21, 2026 |
| Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response (opens in Procura)Solicitation · NAICS 541714Free account: full notice, dates, attachments | BARDA - ASPR / DAAPPO / BARDA DCMA | Nov 20, 2026 |
| BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003) (opens in Procura)Solicitation · NAICS 541714Free account: full notice, dates, attachments | BARDA - ASPR / DAAPPO / BARDA DCMA | Oct 18, 2027 |
| Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) (opens in Procura)Solicitation · NAICS 541714Free account: full notice, dates, attachments | BARDA - ASPR / DAAPPO / BARDA DCMA | Sep 25, 2028 |
Contacts
Small business specialists at this sub-agency
- Small business specialistsLocked · 7-day trial or paid plan (name, email and phone with a 7-day trial or paid plan)Office of Assistant Secretary for Preparedness and ResponseSee contacts